Multicentric validation of nomograms based on BC-116 and BC-106 urine peptide biomarker panels for bladder cancer diagnostics and monitoring in two prospective cohorts of patients.
作者信息
Vasdev Nikhil
机构信息
Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, East and North Herts NHS Trust, Stevenage, UK.
School of Life and Medical Sciences, University of Hertfordshire, Hertfordshire, UK.
出版信息
Br J Cancer. 2023 Apr;128(6):929. doi: 10.1038/s41416-023-02142-z. Epub 2023 Mar 1.
Abstract
摘要
相似文献
1
Multicentric validation of nomograms based on BC-116 and BC-106 urine peptide biomarker panels for bladder cancer diagnostics and monitoring in two prospective cohorts of patients.
Br J Cancer. 2023 Apr;128(6):929. doi: 10.1038/s41416-023-02142-z. Epub 2023 Mar 1.
2
Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients.
Br J Cancer. 2022 Nov;127(11):2043-2051. doi: 10.1038/s41416-022-01992-3. Epub 2022 Oct 3.
3
Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study.
Clin Cancer Res. 2016 Aug 15;22(16):4077-86. doi: 10.1158/1078-0432.CCR-15-2715. Epub 2016 Mar 29.
4
Nomograms including the UBC Rapid test to detect primary bladder cancer based on a multicentre dataset.
BJU Int. 2022 Dec;130(6):754-763. doi: 10.1111/bju.15677. Epub 2022 Jan 11.
5
Proteomic research and diagnosis in bladder cancer: state of the art review.
Int Braz J Urol. 2021 May-Jun;47(3):503-514. doi: 10.1590/S1677-5538.IBJU.2021.99.02.
6
Urine cell-based DNA methylation classifier for monitoring bladder cancer.
Clin Epigenetics. 2018 May 30;10:71. doi: 10.1186/s13148-018-0496-x. eCollection 2018.
7
A urinary microRNA (miR) signature for diagnosis of bladder cancer.
Urol Oncol. 2018 Dec;36(12):531.e1-531.e8. doi: 10.1016/j.urolonc.2018.09.006. Epub 2018 Oct 12.
8
The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review.
Epigenomics. 2018 May;10(5):673-687. doi: 10.2217/epi-2017-0156. Epub 2018 Apr 25.
9
Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Medicine (Baltimore). 2019 Nov;98(44):e17725. doi: 10.1097/MD.0000000000017725.
10
Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
Dis Markers. 2021 Oct 21;2021:3385058. doi: 10.1155/2021/3385058. eCollection 2021.
引用本文的文献
1
Risk factors analysis and risk prediction model for failed back surgery syndrome: A prospective cohort study.
Heliyon. 2024 Nov 22;11(1):e40607. doi: 10.1016/j.heliyon.2024.e40607. eCollection 2025 Jan 15.
2
Peptide Biomarkers - An Emerging Diagnostic Tool and Current Applicable Assay.
Curr Protein Pept Sci. 2025;26(3):167-184. doi: 10.2174/0113892037315736240907131856.
3
Nomogram-based risk assessment for emergency cervical cerclage failure in patients with cervical insufficiency.
Heliyon. 2024 Jun 13;10(13):e32923. doi: 10.1016/j.heliyon.2024.e32923. eCollection 2024 Jul 15.
4
Risk factors analysis and risk prediction model construction of non-specific low back pain: an ambidirectional cohort study.
J Orthop Surg Res. 2023 Jul 29;18(1):545. doi: 10.1186/s13018-023-03945-9.
本文引用的文献
1
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era.
Nat Rev Urol. 2021 Apr;18(4):185-187. doi: 10.1038/s41585-020-00419-z.
2
Urinary biomarkers in bladder cancer: A review of the current landscape and future directions.
Urol Oncol. 2021 Jan;39(1):41-51. doi: 10.1016/j.urolonc.2020.08.016. Epub 2020 Sep 9.
3
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer.
Urol Oncol. 2015 Feb;33(2):66.e25-31. doi: 10.1016/j.urolonc.2014.06.008. Epub 2014 Jul 15.
4
Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement.
Int J Clin Exp Pathol. 2012;5(9):882-91. Epub 2012 Oct 20.
5
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses.
Urology. 2003 Jan;61(1):109-18; discussion 118. doi: 10.1016/s0090-4295(02)02136-2.
Zotero 插件